advertising
-
1.
Schaper NC, Andros G, Apelqvist J, et al: Diagnosis and treatment of peripheral arterial disease in diabetic patients with a foot ulcer: a progress report of the International Working Group on the Diabetic Foot. Diabetes Metab Res Rev 28: 218, 2012.
-
2.
Frykberg RG, Zgonis T, Armstrong DC, et al: Diabetic foot disorders: a clinical practice guideline (2006 revision). J Foot Ankle Surg 45: S1, 2006.
-
3.
Hingorani A, LaMuraglia GM, Henke P, et al: The management of the diabetic foot: a clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. J Vasc Surg 63: 3S, 2016.
-
4.
Sumpio BE, Armstrong DG, Lavery LA, et al: The role of interdisciplinary team approach in the management of the diabetic foot: a joint statement from the Society for Vascular Surgery and the American Podiatric Medical Association. J Vasc Surg 51: 1504, 2010.
-
5.
Pinzur MS, Slovenkai MP, Trepman E, et al: Guidelines for diabetic foot care: recommendations endorsed by the Diabetes Committee of the American Orthopaedic Foot and Ankle Society. Foot Ankle Int 26: 113, 2005.
-
6.
Lipsky BA, Berendt AR, Cornia PB, et al: 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 54: e132, 2012.
-
7.
Zhang JQ, Curran T, McCallum JC, et al: Risk factors for readmission after lower extremity bypass in the American College of Surgeons National Surgery Quality Improvement Program. J Vasc Surg 59: 1211, 2014.
-
8.
Greenblatt DY, Rajamanickam V, Mell MW: Predictors of surgical site infection after open lower extremity revascularization. J Vasc Surg 54: 433, 2011.
-
9.
Crawford RS, Cambria RP, Abularrage CJ, et al: Preoperative functional status predicts perioperative outcomes after infrainguinal bypass surgery. J Vasc Surg 51: 351, 2010.
-
10.
LaMuraglia GM, Conrad MF, Chung T, et al: Significant perioperative morbidity accompanies contemporary infrainguinal bypass surgery: an NSQIP report. J Vasc Surg 50: 299, 2009.
-
11.
Madenci AL, Ozaki CK, Gupta N, et al: Perioperative outcomes of elective inflow revascularization for lower extremity claudication in the American College of Surgeons National Surgical Quality Improvement Program database. Am J Surg 212: 461, 2016.
-
12.
Nakazawa KR, Cornwall JW, Rao A, et al: Trends, factors, and disparities associated with length of stay after lower extremity bypass for tissue loss. J Vasc Surg 73: 190, 2021.
-
13.
Najafian A, Selvarajah S, Schneider EB, et al: Thirty-day readmission after lower extremity bypass in diabetic patients. J Surg Res 200: 356, 2016.
-
14.
Collins TC, Johnson M, Henderson W, et al: Lower extremity nontraumatic amputation among veterans with peripheral arterial disease: is race an independent factor? Med Care 40: 1106, 2002.
-
15.
Giles KA, Hamdan AD, Pomposelli FB, et al: Body mass index: surgical site infections and mortality after lower extremity bypass from the National Surgical Quality Improvement Program 2005-2007. Ann Vasc Surg 24: 48, 2010.
-
16.
Singh N, Sidawy AN, DeZee KJ, et al: Factors associated with early failure of infrainguinal lower extremity arterial bypass. J Vasc Surg 47: 556, 2008.
-
17.
Chen SL, Whealon MD, Kabutey NB, et al: Outcomes of open and endovascular lower extremity revascularization in active smokers with advanced peripheral arterial disease. J Vasc Surg 65: 1680, 2017.
-
18.
Rao A, Baldwin M, Cornwall J, et al: Contemporary outcomes of surgical revascularization of the lower extremity in patients on dialysis. J Vasc Surg 66: 167, 2017.
-
19.
Lancaster RT, Conrad MF, Patel VI, et al: Predictors of early graft failure after infrainguinal bypass surgery: a risk-adjusted analysis from the NSQIP. Eur J Vasc Endovasc Surg 43: 549, 2012.
-
20.
O’Hare AM, Sidawy AN, Feinglass J, et al: Influence of renal insufficiency on limb loss and mortality after initial lower extremity surgical revascularization. J Vasc Surg 39: 709, 2004.
-
21.
Aziz F, Bohr T, Lehman EB: Wound disruption after lower extremity bypass surgery is a predictor of subsequent development of wound infection. Ann Vasc Surg 43: 176, 2017.
-
22.
Aziz F, Lehman EB, Reed AB: Unplanned return to operating room after lower extremity arterial bypass is an independent predictor for hospital readmission. J Vasc Surg 63: 678, 2016.
-
23.
Aziz F, Chu Y, Lehman EB: Lower extremity bypass surgery on patients transferred from other hospitals is associated with increased morbidity and mortality. Ann Vasc Surg 41: 205, 2017.
-
24.
Aziz F, Lehman E, Blebea J, et al: Postoperative complications after lower extremity bypass increase the risk of new deep vein thrombosis. Phlebology 33: 558, 2018.
-
25.
Peacock MR, Shah NK, Farber A, et al: Index complications predict secondary complications after infrainguinal lower extremity bypass for critical limb ischemia. J Vasc Surg 65: 1344, 2017.
-
26.
Robinson WP, Mehaffey JH, Hawkins RB, et al: Lower extremity bypass and endovascular intervention for critical limb ischemia fail to meet Society for Vascular Surgery’s objective performance goals for limb-related outcomes in a contemporary national cohort. J Vasc Surg 68: 1438, 2018.
-
27.
Kote GS, Bhat AN, Thajuddeen K, et al: Peripheral insensate neuropathy: is height a risk factor? J Clin Diagn Res 7: 296, 2013.
-
28.
Cheng YJ, Gregg EW, Kahn HS, et al: Peripheral insensate neuropathy: a tall problem for US adults? Am J Epidemiol 164: 873, 2006.
-
29.
Sorensen L, Molyneaux L, Yue DK: Insensate versus painful diabetic neuropathy: the effects of height, gender, ethnicity and glycaemic control. Diabetes Res Clin Pract 57: 45, 2002.
-
30.
Bjornerem A, Bui QM, Ghasem-Zadeh A, et al: Fracture risk and height: an association partly accounted for by cortical porosity of relatively thinner cortices. J Bone Miner Res 28: 2017, 2013.
-
31.
Ferriol C, Tremols S, Jimenez C, et al: Are there height-dependent differences in subclinical vascular disease in hypertensive patients? J Clin Hypertens 16: 70, 2014.
-
32.
Roetker NS, Armasu SM, Pankow JS, et al: Taller height as a risk factor for venous thromboembolism: a Mendelian randomization meta-analysis. J Thromb Haemost 15: 1334, 2017.
-
33.
Tseng CH: Prevalence of lower-extremity amputation among patients with diabetes mellitus: is height a factor? CMAJ 174: 319, 2006.
-
34.
Wukich DK, Crim BE, Frykberg RG, et al: Neuropathy and poorly controlled diabetes increase the rate of surgical site infection after foot and ankle surgery. J Bone Joint Surg Am 96: 832, 2014.
-
35.
Wukich DK, McMillen RL, Lowery NJ, et al: Surgical site infections after foot and ankle surgery: a comparison of patients with and without diabetes. Diabetes Care 34: 2211, 2011.
-
36.
Wukich DK, Joseph A, Ryan M, et al: Outcomes of ankle fractures in patients with uncomplicated versus complicated diabetes. Foot Ankle Int 32: 120, 2011.
-
37.
Menez SP, Kwak L, Ding N, et al: The association of height with incident peripheral arterial disease in the Arthrosclerosis Risk in Communities (ARIC) study. Circulation 139: P308, 2019.
-
38.
Fu X, Zhao S, Mao H, et al: Association of height with peripheral arterial disease in type 2 diabetes. J Endocrinol Invest 38: 57, 2015.
-
39.
User Guide for the 2018 ACS NSQIP Participant Use Data File. Available at: https://www.facs.org/quality-programs/data-and-registries/acs-nsqip/participant-use-data-file/. Published October 2019. Accessed July 24, 2024.
The Effect of Height on Adverse Short-Term Outcomes After Lower-Extremity Bypass Surgery in Patients with Diabetes Mellitus
Search for other papers by Kushkaran Kaur in
Current site
Google Scholar
PubMed
Search for other papers by Rhonda S. Cornell in
Current site
Google Scholar
PubMed
Search for other papers by Lawrence Oresanya in
Current site
Google Scholar
PubMed
Search for other papers by Andrew J. Meyr in
Current site
Google Scholar
PubMed
Background: We evaluated adverse short-term outcomes after open lower-extremity bypass surgery in patients with diabetes mellitus with a comparison performed based on patient height.
Methods: The American College of Surgeons National Surgical Quality Improvement Program database was analyzed to select patients with Current Procedural Terminology codes 35533, 35540, 35556, 35558, 35565, 35566, 35570, and 35571 and with the diagnosis of diabetes mellitus. This resulted in 83 patients 60 inches or less in height, 1,084 between 60 and 72 inches, and 211 patients 72 inches and taller.
Results: No differences were observed among groups with respect to the development of a superficial surgical site infection (9.6% versus 6.4% versus 5.7%; P = .458), deep incisional infection (1.2% versus 1.4% versus 2.8%; P = .289), sepsis (2.4% versus 2.0% versus 2.8%; P = .751), unplanned reoperation (19.3% versus 15.6% versus 21.8%; P = .071), or unplanned hospital readmission (19.3% versus 14.8% versus 17.1%; P = .573). A significant difference was observed among groups in the development of a wound disruption (4.8% versus 1.3% versus 4.7%; P = .001). A multivariate regression analysis was performed of the wound disruption outcome with the variables of age, sex, race, ethnicity, height, weight, current smoker, and open wound/wound infection. Race (P = .025) and weight (P = .003) were found to be independently associated with wound disruption, but height was not (P = .701).
Conclusions: The results of this investigation demonstrate no significant differences in short-term adverse outcomes after lower-extremity bypass surgery based on patient height.
advertising
